News | March 11, 2015

Society of Thoracic Surgeons Launches Congenital Heart Surgery Database

Public reporting of risk-adjusted surgical outcomes aims to better inform patients

STS, CHSD, congenital heart, trial, surgery, database, pediatric

March 11, 2015 —The Society of Thoracic Surgeons (STS) has released the first publicly accessible national report of surgical outcomes from its Congenital Heart Surgery Database (CHSD), a component of the STS National Database. Public reporting results are available at www.sts.org/publicreporting.

“The public reporting of these results represents something entirely new, in that this is the first time ever that pediatric and congenital heart surgery outcomes in the United States have been made available to the public on a national level,” said Jeffrey P. Jacobs, M.D., chair of the STS Public Reporting Task Force and professor of surgery at The Johns Hopkins University. “STS has always been a strong advocate of transparency within the specialty. We believe that our patients and their families have the right to know the outcomes of cardiothoracic surgery procedures so that they can make well-informed decisions.”

The CHSD is the largest database in North America focused exclusively on pediatric and congenital cardiac malformations; more than 95 percent of hospitals in the United States that perform pediatric heart surgery submit surgical data.

For the first round of STS Public Reporting Online from the CHSD, 25 sites (22.7 percent) participated, which closely resembles the level of participation in the first round of public reporting from the STS Adult Cardiac Surgery Database (ACSD) that began five years ago. ACSD participation is now at 42.7 percent (453 sites).

For the CHSD participants who volunteered to publicly report, STS released four-year observed, expected and risk-adjusted center-level operative mortality rates for the aggregate of all patients, as well as for patients stratified on the basis of the five STAT Mortality Categories (surgical procedures grouped by complexity). Outcomes have been risk-adjusted to take into account procedural complexity and individual patient factors such as age, weight, non-cardiac abnormalities (including chromosomal abnormalities), previous surgeries, preoperative co-morbidities and other medical conditions that could affect results.

“Reporting hospital surgical outcomes using risk-adjusted analysis is extremely important because it allows for a fair assessment, on a level playing field, of outcomes across hospitals that treat different populations of patients,” said Marshall L. Jacobs, M.D., chair of the STS CHSD Task Force. “As pediatric and congenital cardiac surgeons, we perform operations on patients born with a wide variety of heart defects of varying complexity, and many patients have additional risk factors. Adjusting for these risk factors allows us to better understand reported mortality rates, especially for centers that operate on the most challenging patients.”

Unlike ACSD public reporting, which includes a star-ratings system to report hospital outcomes, star ratings are not currently reported for the CHSD. Star ratings, based on a hospital’s overall risk-adjusted observed-to-expected operative mortality ratio, will be added to the summer 2015 release.

“Public access to outcomes data for adult heart surgery and now pediatric and congenital heart surgery is at an unprecedented level and will continue to increase,” said Dr. Jeffrey Jacobs. “Next year, we plan to add public reporting for STS General Thoracic Surgery Database participants, starting with outcomes for lobectomy in cancer patients.”

For more information: www.sts.org


Related Content

News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
Subscribe Now